I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
Reservation Policy & Attendance Limit: This event has an attendance limit of 300 people and seats will be reserved on a first-come, first-served basis. Please be sure to register as soon as possible to reserve your seat and ensure your attendance.
*We strive to be inclusive. All are welcome to attend!